Showing content from https://pubmed.ncbi.nlm.nih.gov/35580655/ below:
Impact of the COVID-19 Pandemic on Fecal Immunochemical Testing, Colonoscopy Services, and Colorectal Neoplasia Detection in a Large United States Community-based Population
. 2022 Sep;163(3):723-731.e6. doi: 10.1053/j.gastro.2022.05.014. Epub 2022 May 14. Impact of the COVID-19 Pandemic on Fecal Immunochemical Testing, Colonoscopy Services, and Colorectal Neoplasia Detection in a Large United States Community-based Population Angela Y Lam 2 , Christopher D Jensen 3 , Amy R Marks 3 , Jessica Badalov 3 , Evan Layefsky 3 , Kevin Kao 4 , Ngoc J Ho 5 , Joanne E Schottinger 6 , Nirupa R Ghai 7 , Cheryl M Carlson 5 , Ethan A Halm 8 , Beverly Green 9 , Dan Li 10 , Douglas A Corley 11 , Theodore R Levin 12
Affiliations
Affiliations
- 1 Department of Gastroenterology, Kaiser Permanente San Francisco Medical Center, San Francisco, California; Division of Research, Kaiser Permanente Northern California, Oakland, California. Electronic address: Jeffrey.K.Lee@kp.org.
- 2 Department of Gastroenterology, Kaiser Permanente San Francisco Medical Center, San Francisco, California.
- 3 Division of Research, Kaiser Permanente Northern California, Oakland, California.
- 4 Department of Gastroenterology, Kaiser Permanente Downey Medical Center, Downey, California; Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California.
- 5 Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California.
- 6 Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California.
- 7 Department of Quality and Systems of Care, Kaiser Permanente Southern California, Pasadena, California.
- 8 Department of Population and Data Sciences and the Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas.
- 9 Kaiser Permanente Washington Health Research Institute, Seattle, Washington.
- 10 Division of Research, Kaiser Permanente Northern California, Oakland, California; Department of Gastroenterology, Kaiser Permanente Santa Clara Medical Center, Santa Clara, California.
- 11 Department of Gastroenterology, Kaiser Permanente San Francisco Medical Center, San Francisco, California; Division of Research, Kaiser Permanente Northern California, Oakland, California.
- 12 Division of Research, Kaiser Permanente Northern California, Oakland, California; Department of Gastroenterology, Kaiser Permanente Walnut Creek Medical Center, Walnut Creek, California.
Item in Clipboard
Impact of the COVID-19 Pandemic on Fecal Immunochemical Testing, Colonoscopy Services, and Colorectal Neoplasia Detection in a Large United States Community-based Population
Jeffrey K Lee et al. Gastroenterology. 2022 Sep.
. 2022 Sep;163(3):723-731.e6. doi: 10.1053/j.gastro.2022.05.014. Epub 2022 May 14. Authors Jeffrey K Lee 1 , Angela Y Lam 2 , Christopher D Jensen 3 , Amy R Marks 3 , Jessica Badalov 3 , Evan Layefsky 3 , Kevin Kao 4 , Ngoc J Ho 5 , Joanne E Schottinger 6 , Nirupa R Ghai 7 , Cheryl M Carlson 5 , Ethan A Halm 8 , Beverly Green 9 , Dan Li 10 , Douglas A Corley 11 , Theodore R Levin 12 Affiliations
- 1 Department of Gastroenterology, Kaiser Permanente San Francisco Medical Center, San Francisco, California; Division of Research, Kaiser Permanente Northern California, Oakland, California. Electronic address: Jeffrey.K.Lee@kp.org.
- 2 Department of Gastroenterology, Kaiser Permanente San Francisco Medical Center, San Francisco, California.
- 3 Division of Research, Kaiser Permanente Northern California, Oakland, California.
- 4 Department of Gastroenterology, Kaiser Permanente Downey Medical Center, Downey, California; Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California.
- 5 Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California.
- 6 Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California.
- 7 Department of Quality and Systems of Care, Kaiser Permanente Southern California, Pasadena, California.
- 8 Department of Population and Data Sciences and the Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas.
- 9 Kaiser Permanente Washington Health Research Institute, Seattle, Washington.
- 10 Division of Research, Kaiser Permanente Northern California, Oakland, California; Department of Gastroenterology, Kaiser Permanente Santa Clara Medical Center, Santa Clara, California.
- 11 Department of Gastroenterology, Kaiser Permanente San Francisco Medical Center, San Francisco, California; Division of Research, Kaiser Permanente Northern California, Oakland, California.
- 12 Division of Research, Kaiser Permanente Northern California, Oakland, California; Department of Gastroenterology, Kaiser Permanente Walnut Creek Medical Center, Walnut Creek, California.
Item in Clipboard
Abstract
Background & aims: The COVID-19 pandemic has affected clinical services globally, including colorectal cancer (CRC) screening and diagnostic testing. We investigated the pandemic's impact on fecal immunochemical test (FIT) screening, colonoscopy utilization, and colorectal neoplasia detection across 21 medical centers in a large integrated health care organization.
Methods: We performed a retrospective cohort study in Kaiser Permanente Northern California patients ages 18 to 89 years in 2019 and 2020 and measured changes in the numbers of mailed, completed, and positive FITs; colonoscopies; and cases of colorectal neoplasia detected by colonoscopy in 2020 vs 2019.
Results: FIT kit mailings ceased in mid-March through April 2020 but then rebounded and there was an 8.7% increase in kits mailed compared with 2019. With the later mailing of FIT kits, there were 9.0% fewer FITs completed and 10.1% fewer positive tests in 2020 vs 2019. Colonoscopy volumes declined 79.4% in April 2020 compared with April 2019 but recovered to near pre-pandemic volumes in September through December, resulting in a 26.9% decline in total colonoscopies performed in 2020. The number of patients diagnosed by colonoscopy with CRC and advanced adenoma declined by 8.7% and 26.9%, respectively, in 2020 vs 2019.
Conclusions: The pandemic led to fewer FIT screenings and colonoscopies in 2020 vs 2019; however, after the lifting of shelter-in-place orders, FIT screenings exceeded, and colonoscopy volumes nearly reached numbers from those same months in 2019. Overall, there was an 8.7% reduction in CRC cases diagnosed by colonoscopy in 2020. These data may help inform the development of strategies for CRC screening and diagnostic testing during future national emergencies.
Keywords: COVID-19; Cancer; Colonoscopy; Pandemic; Screening.
Copyright © 2022 AGA Institute. Published by Elsevier Inc. All rights reserved.
PubMed Disclaimer
Figures
Figure 1
The number of patients who…
Figure 1
The number of patients who were mailed a FIT kit, completed the FIT,…
Figure 1
The number of patients who were mailed a FIT kit, completed the FIT, and tested positive in 2019 and 2020.
Figure 2
The number of colonoscopies performed,…
Figure 2
The number of colonoscopies performed, advanced adenomas detected, and CRCs detected in 2019…
Figure 2
The number of colonoscopies performed, advanced adenomas detected, and CRCs detected in 2019 and 2020.
Figure 3
The number of colonoscopies performed…
Figure 3
The number of colonoscopies performed in 2019 and 2020 by procedure indication.
Figure 3
The number of colonoscopies performed in 2019 and 2020 by procedure indication.
Supplementary Figure 1
Flow diagram summarizing algorithm…
Supplementary Figure 1
Flow diagram summarizing algorithm used to assign colonoscopy indication.
Supplementary Figure 1
Flow diagram summarizing algorithm used to assign colonoscopy indication.
Similar articles
- A delay in the diagnosis of colorectal cancer screened by fecal immunochemical tests during the COVID-19 pandemic: a longitudinal cohort study.
Ishibashi F, Shida D, Suzuki S, Nagai M, Mochida K, Morishita T. Ishibashi F, et al. Int J Colorectal Dis. 2022 Dec;37(12):2543-2546. doi: 10.1007/s00384-022-04270-z. Epub 2022 Nov 16. Int J Colorectal Dis. 2022. PMID: 36383225 Free PMC article.
- Diagnostic Yield of One-Time Colonoscopy vs One-Time Flexible Sigmoidoscopy vs Multiple Rounds of Mailed Fecal Immunohistochemical Tests in Colorectal Cancer Screening.
Grobbee EJ, van der Vlugt M, van Vuuren AJ, Stroobants AK, Mallant-Hent RC, Lansdorp-Vogelaar I, Bossuyt PMM, Kuipers EJ, Dekker E, Spaander MCW. Grobbee EJ, et al. Clin Gastroenterol Hepatol. 2020 Mar;18(3):667-675.e1. doi: 10.1016/j.cgh.2019.08.015. Epub 2019 Aug 13. Clin Gastroenterol Hepatol. 2020. PMID: 31419575 Clinical Trial.
- Program Components and Results From an Organized Colorectal Cancer Screening Program Using Annual Fecal Immunochemical Testing.
Selby K, Jensen CD, Levin TR, Lee JK, Schottinger JE, Zhao WK, Corley DA, Doubeni CA. Selby K, et al. Clin Gastroenterol Hepatol. 2022 Jan;20(1):145-152. doi: 10.1016/j.cgh.2020.09.042. Epub 2020 Sep 30. Clin Gastroenterol Hepatol. 2022. PMID: 33010408 Free PMC article.
- Impact of the COVID-19 Pandemic on Colorectal Cancer Screening: a Systematic Review.
Mazidimoradi A, Tiznobaik A, Salehiniya H. Mazidimoradi A, et al. J Gastrointest Cancer. 2022 Sep;53(3):730-744. doi: 10.1007/s12029-021-00679-x. Epub 2021 Aug 18. J Gastrointest Cancer. 2022. PMID: 34406626 Free PMC article. Review.
- Guaiac-based faecal occult blood tests versus faecal immunochemical tests for colorectal cancer screening in average-risk individuals.
Grobbee EJ, Wisse PHA, Schreuders EH, van Roon A, van Dam L, Zauber AG, Lansdorp-Vogelaar I, Bramer W, Berhane S, Deeks JJ, Steyerberg EW, van Leerdam ME, Spaander MC, Kuipers EJ. Grobbee EJ, et al. Cochrane Database Syst Rev. 2022 Jun 6;6(6):CD009276. doi: 10.1002/14651858.CD009276.pub2. Cochrane Database Syst Rev. 2022. PMID: 35665911 Free PMC article. Review.
Cited by
- Colonoscopy Following an Abnormal Fecal Test Result from an Annual Colorectal Cancer Screening Program in a Federally Qualified Health Center.
Escaron AL, Garcia J, Petrik AF, Ruiz E, Nyongesa DB, Thompson JH, Coronado GD. Escaron AL, et al. J Prim Care Community Health. 2022 Jan-Dec;13:21501319221138423. doi: 10.1177/21501319221138423. J Prim Care Community Health. 2022. PMID: 36448466 Free PMC article.
- The impact of COVID-19 on endoscopy and cancer screening: a focus on access and equity.
Gardner JG, Feld LD. Gardner JG, et al. Therap Adv Gastroenterol. 2023 May 10;16:17562848231173334. doi: 10.1177/17562848231173334. eCollection 2023. Therap Adv Gastroenterol. 2023. PMID: 37180362 Free PMC article. Review.
- Initial and persistent changes in cancer screening in a US Midwestern community health center network following the onset of COVID-19.
An LC, Zarr-McDonagh A, Krumm A, Bacon E, Liebrecht C, Rennaker H, Syed F, Resnicow K. An LC, et al. Prev Med Rep. 2025 Mar 18;53:103030. doi: 10.1016/j.pmedr.2025.103030. eCollection 2025 May. Prev Med Rep. 2025. PMID: 40231219 Free PMC article.
- Colorectal Cancer Screening Amid COVID-19 in Japan: Analysis From the 2021-2022 JACSIS Study.
Saito H, Abubakar AK, Ozaki A, Hori D, Murakami M, Kaneda Y, Tsubokura M, Tabuchi T. Saito H, et al. Cancer Med. 2025 Apr;14(8):e70859. doi: 10.1002/cam4.70859. Cancer Med. 2025. PMID: 40249284 Free PMC article.
- Impact and Recovery from COVID-19-Related Disruptions in Colorectal Cancer Screening and Care in the US: A Scenario Analysis.
van den Puttelaar R, Lansdorp-Vogelaar I, Hahn AI, Rutter CM, Levin TR, Zauber AG, Meester RGS. van den Puttelaar R, et al. Cancer Epidemiol Biomarkers Prev. 2023 Jan 9;32(1):22-29. doi: 10.1158/1055-9965.EPI-22-0544. Cancer Epidemiol Biomarkers Prev. 2023. PMID: 36215205 Free PMC article.
References
-
- Dong E., Du H., Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020;20:533–534. - PMC - PubMed
-
- Centers for Medicare & Medicaid Services Non-emergent, elective medical services, and treatment recommendations. https://www.cdc.gov/coronavirus/2019-ncov/healthcare-facilities/index.html Available at: Accessed December 4, 2021.
-
- Lui T.K., Leung K., Guo C.-G., et al. Impacts of COVID-19 pandemic on gastrointestinal endoscopy volume and diagnosis of gastric and colorectal cancers: a population-based study. Gastroenterology. 2020;159:1164–1166.e3. - PMC - PubMed
-
- Morris E., Goldacre R., Spata E., et al. Impact of the COVID-19 pandemic on the detection and management of colorectal cancer in England: a population-based study. Lancet Gastroenterol Hepatol. 2021;6:199–208. - PMC - PubMed
-
- Lantinga M., Theunissen F., Borg P Ter, et al. Impact of the COVID-19 pandemic on gastrointestinal endoscopy in the Netherlands: analysis of a prospective endoscopy database. Endoscopy. 2021;53:166–170. - PMC - PubMed
RetroSearch is an open source project built by @garambo
| Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3